Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.

Clinical trial NCT05392647 · UNKNOWN

Trial details

NCT number: NCT05392647
Sponsor: Tongji Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2022-07-01
Primary completion: 2024-07-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.